Solvemed Blog

Clinical Value of Quantative Pupillometry in Stroke Care

Exploring how quantitative pupillometry enhances stroke monitoring and improves early detection of neurological decline.

Education partnership for the 38th Annual British Association of Critical Care Nurses  

Solvemed expanded its international presence by partnering with the British Association of Critical Care Nurses conference in Nottingham, following successful showcases at major US medical conferences.

Solvemed Showcases PuRe™ Pupillometer at International Stroke Conference (ISC) 2025

Solvemed demonstrates AI-driven smartphone-based pupillometry technology for improved stroke care at ISC 2025.

The Effect of Ambient Light Conditions on Hardware Pupillometer Measurements

Research validates environmental factors in automated pupillometry: Charlene Ong study reveals ambient light impact on neurointensive care measurements.

PuRe Score: Advancing Objective Pupillometry

In today’s fast-paced clinical environment, swiftly and accurately evaluating a patient's neurological status is vital. Yet traditional pupillary assessments — based on visual observation — can be inconsistent and prone to subjective interpretation. To solve this long-standing challenge, Solvemed Inc. introduces a breakthrough in neurological evaluation: the Pupil Reactivity (PuRe) score.

How Ambient Light Conditions Impact Infrared Pupillometry in ICU

Simple lighting changes could impact neurological assessments: Study reveals how ICU environments might influence automated pupil monitoring accuracy.

Ambient Light Effects in Pupillometry

Ambient light creates measurement errors in neurointensive care: New lighting-corrected pupillometry prevents misclassification of critically ill patients

Clinical Workflow Optimization with PuRe Pupillometer EMR Integration

iPhone-based pupillometry reduces assessment time from 100 to 21 seconds: Automated documentation eliminates manual steps in ICU monitoring

Solvemed at the Emergency Nurses Association Annual Conference 2023

Our team connects with emergency nursing professionals at ENA2023, showcasing AI-powered PuRe™ Pupillometer for critical triage assessments.

Solvemed attending CHEST 2023 Conference

Solvemed showcases AI-driven neuromonitoring technology at CHEST 2023, connecting with global critical care and pulmonary specialists.

Solvemed Presents AI-Powered Pupillometer at Neurocritical Care Society Annual Meeting

Solvemed showcases PuRe™ Pupillometer technology at premier neurocritical care conference, demonstrating breakthrough AI-powered medical device for ICU applications.

New Frontiers in Space Medicine: Pupillometry for Astronaut Neuro-Ophthalmic Health

Solvemed strengthens its commitment to supporting neuro-ophthalmic care on Earth and in space.

AI in Acute Neurology: Transforming Patient Care

How AI is transforming acute neurology care and the role of neurologists

Solvemed Appoints Marek Dziubinski, Ph.D., to its Board of Directors

A proven pioneer in medical technology and recognized expert in physiological signal analysis, Marek has played a pivotal role as Solvemed's CTO. His transition to the Board marks a strategic inflection point as the company scales its AI Pupillometry System toward broader clinical adoption.

Solvemed’s AI-Powered Pupillometry: A Breakthrough in Standardized Neurological Assessments at ISC 2025

Clinical trial completion with Queen Mary University of London  &  Barts Health NHS Trust 

Today we are incredibly proud to conclude the clinical trial Solvemed has run jointly with Queen Mary University of London & Barts Health NHS Trust, in collaboration with Professor Alastair Noyce's clinical neuroscience research group investigating the relationship of Solvemed’s novel digital biomarkers and the onset and development of Parkinson’s disease.